Answers are grounded in this paper and cite their sources.
Review examines how focusing on disease activity can improve outcomes in obstructive airway diseases, indicating a need for early intervention.
The discovery of clinically accessible biomarkers that identify patients with obstructive airway disease who are at risk of adverse outcomes along with the availability of highly effective targeted treatments has increased interest in earlier target intervention and disease modification. In this review I argue that the time is ripe to move the focus from diseases entities that require disease related damage (‘too late disease') to a new framework where the focus is on identification of high disease activity (‘high risk disease'). I review the evidence in favour of this approach and identify gaps in this evidence. Finally, I discuss opportunities to operationalise this new approach.
No takes yet. Share an insight, caveat, or question.
Ian Pavord (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: